Hydroxychloroquine: Pharmacokinetics and Toxicity

Table 3

Main characteristics of extreme outliers for COVID-19 patients.

Patient	Sex	Day	Age (years)	HCQ serum level (μg/mL)	Clinical outcome	Drug-related adverse event	Death
1	F	2	65	0.804	Good	No	No
7	F	16	37	1.452	Good	No	No
9	F	17^$	89	1.32	Poor	No	Yes

Patient already taking HCQ before COVID-19 for lupus. ^$Treatment duration with HCQ was extended due to persistence of viral shedding and acute respiratory distress.